Powered by

-miRagen Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 12, 2020 - ENP Newswire

BOULDER - miRagen Therapeutics, Inc. (NASDAQ: MGEN), today reported operating highlights and financial results for the quarter and full-year ended December 31, 2019 and provided an outlook for 2020.

'In 2019, we announced a series of changes intended to streamline our focus and operations. As a result, we enter 2020 with the opportunity to deliver several important milestones. We started the year by announcing positive new data for cobomarsen in ATLL patients in January and completed a $ 1...